Drug development
and diagnostics

Research Group:
BioNanoMaterials research group

Jessica Rosenholm
Jessica.rosenholm[at]abo.fi

Pharmaceutical Sciences Laboratory,
Åbo Akademi University

Jessica Rosenholm

Pharmaceutical Sciences Laboratory

Antibacterial, Biomedicine, Biopharmaceuticals, Biotechnology, Cancer, Diagnostics, Drug delivery, Drug solubility, Drug stability, Electron microscopy, Fluorescence spectroscopy, Formulation, FTIR or RAMAN spectroscopy, Imaging software, Infection, Lead optimization, Musculoskeletal disorders, Nanoparticles, Natural products, Organic compounds, Particle morphology, Particle size analysis, Personalized medicine, Pharmacy, Physico-chemical properties, Porosity, Powder flow characterization, Powder X-ray diffraction, Preclinical development, Screening, Skin diseases, Super-resolution imaging, Surface area, Synthetic chemistry, Thermal analysis, Zeta potential

Research Group:
New tools to target harmful inflammations and cancer

Sirpa Jalkanen
sirjal[at]utu.fi

Institute of Biomedicine,
University of Turku

Sirpa Jalkanen

Cell Trafficking in Cancer and Inflammation

Ageing-related diseases, Antibodies, Autoimmune diseases, Basic research, Biochemistry, Biomarker, Biomedicine, Biopharmaceuticals, Breast cancer, Cancer, Cardiovascular diseases, Clinical Medicine, Colorectal cancer, Diagnostics, Disease models, Drug target, Imaging, Immunology, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Lung cancer, Melanoma, Metabolic diseases, Molecular Cell Biology, Molecular diagnostics, Musculoskeletal disorders, Neurological disorders, Obesity, Ovarian cancer, Pathology, Personalized medicine, PET, Prostate cancer, Receptor, Signaling, Skin diseases, Squamous cell carcinoma, Target discovery

Research Group:
Translational imaging and Drug Research

Anne Roivainen
anne.roivainen[at]utu.fi

Turku PET Centre and Turku Center for Disease Modeling,
University of Turku

Anne Roivainen

Roivainen Group

TCDM - Anne Roivainen

http://www.turkucrc.fi/files/272/Roivainen_Anne.pdf

Antibodies, Autoimmune diseases, Biochemistry, Biomedicine, Biomolecular chemistry, Biopharmaceuticals, Cancer, Cardiovascular diseases, Disease models, Imaging, Immunology, In Vivo Diagnostics, Infection, Inflammation, Metabolic diseases, Molecular Cell Biology, PET, Physiology, Receptor, Super-resolution imaging

Research Group:
Computer-aided drug design

Outi Salo-Ahen
osalo[at]abo.fi

Pharmaceutical Sciences and Structural Bioinformatics Laboratory,
Åbo Akademi University

Outi Salo-Ahen

Computer-aided drug design

Antibacterial, Bioinformatics, Biomolecular chemistry, Biopharmaceuticals, Cancer, Drug target, Hit to lead, Infection, Lead optimization, Medicinal chemistry, Molecular modelling, Natural Compounds, Natural products, Pharmacy, Preclinical development, Screening, Structural Biology

Research Group:
Alpha2-Adrenoceptors as targets for drug development

Mika Scheinin
mschein[at]utu.fi

University of Turku, Turku University Hospital and CRST Oy

Mika Scheinin

Clinical Research Services Turku

Ageing-related diseases, Allergy, Antibodies, Assay development, Asthma, Autoimmune diseases, Basic research, Biomarker, Biomedicine, Biopharmaceuticals, Cancer, Cardiovascular diseases, Clinical Medicine, Diabetes, Diagnostics, Disease models, Drug delivery, Drug target, Endocrinology, Imaging, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Medicinal chemistry, Metabolic diseases, Metal disorders, Molecular diagnostics, Musculoskeletal disorders, Natural products, Neurological disorders, Obesity, Organic compounds, Personalized medicine, PET, Pharmacology, Receptor, Screening, Signaling, Skin diseases, Target discovery

Research Group:
Mesoporous drug carriers/ Electrostatics / Pharmaceutical Physics

Jarno Salonen
jarno.salonen[at]utu.fi

Industrial Physics Laboratory,
University of Turku

Jarno Salonen

Biopharmaceuticals, Cancer, Chemical Physics, Diabetes, Drug delivery, Drug solubility, Drug stability, Drug target, Electron microscopy, FTIR or RAMAN spectroscopy, Lead optimization, Microstructure analysis, Nanoparticles, NMR, Obesity, Particle size analysis, Pharmacy, Physico-chemical properties, Physics, Polymorph analysis, Porosity, Powder X-ray diffraction, Preclinical development, Surface area, Thermal analysis, Zeta potential